123 related articles for article (PubMed ID: 35835390)
1. Intestinal Inflammation Promotes MDL-1
Peek CT; Ford CA; Eichelberger KR; Jacobse J; Torres TP; Maseda D; Latour YL; Piazuelo MB; Johnson JR; Byndloss MX; Wilson KT; Rathmell JC; Goettel JA; Cassat JE
Cell Mol Gastroenterol Hepatol; 2022; 14(4):731-750. PubMed ID: 35835390
[TBL] [Abstract][Full Text] [Related]
2. What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?
de Vries TJ; El Bakkali I; Kamradt T; Schett G; Jansen IDC; D'Amelio P
Front Immunol; 2019; 10():505. PubMed ID: 30941138
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome profiling of osteoclast subsets associated with arthritis: A pathogenic role of CCR2
Filipović M; Flegar D; Aničić S; Šisl D; Kelava T; Kovačić N; Šućur A; Grčević D
Front Immunol; 2022; 13():994035. PubMed ID: 36591261
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-23 Regulates Inflammatory Osteoclastogenesis via Activation of CLEC5A(+) Osteoclast Precursors.
Furuya H; Nguyen CT; Gu R; Hsieh SL; Maverakis E; Adamopoulos IE
Arthritis Rheumatol; 2023 Aug; 75(8):1477-1489. PubMed ID: 36787107
[TBL] [Abstract][Full Text] [Related]
5. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
Inui M; Kikuchi Y; Aoki N; Endo S; Maeda T; Sugahara-Tobinai A; Fujimura S; Nakamura A; Kumanogoh A; Colonna M; Takai T
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4816-21. PubMed ID: 19251634
[TBL] [Abstract][Full Text] [Related]
6. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential.
Yang J; Park OJ; Kim J; Kwon Y; Yun CH; Han SH
J Cell Physiol; 2019 Dec; 234(12):23033-23042. PubMed ID: 31127629
[TBL] [Abstract][Full Text] [Related]
7. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis.
Joyce-Shaikh B; Bigler ME; Chao CC; Murphy EE; Blumenschein WM; Adamopoulos IE; Heyworth PG; Antonenko S; Bowman EP; McClanahan TK; Phillips JH; Cua DJ
J Exp Med; 2010 Mar; 207(3):579-89. PubMed ID: 20212065
[TBL] [Abstract][Full Text] [Related]
8. Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis.
Ikić Matijašević M; Flegar D; Kovačić N; Katavić V; Kelava T; Šućur A; Ivčević S; Cvija H; Lazić Mosler E; Kalajzić I; Marušić A; Grčević D
Clin Exp Immunol; 2016 Dec; 186(3):321-335. PubMed ID: 27612450
[TBL] [Abstract][Full Text] [Related]
9. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
[TBL] [Abstract][Full Text] [Related]
10. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.
Yao Z; Xing L; Qin C; Schwarz EM; Boyce BF
J Biol Chem; 2008 Apr; 283(15):9917-24. PubMed ID: 18250170
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
13. Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.
Sućur A; Katavić V; Kelava T; Jajić Z; Kovačić N; Grčević D
Int Orthop; 2014 Sep; 38(9):1893-903. PubMed ID: 24913769
[TBL] [Abstract][Full Text] [Related]
14. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin.
Andreev D; Liu M; Weidner D; Kachler K; Faas M; Grüneboom A; Schlötzer-Schrehardt U; Muñoz LE; Steffen U; Grötsch B; Killy B; Krönke G; Luebke AM; Niemeier A; Wehrhan F; Lang R; Schett G; Bozec A
J Clin Invest; 2020 Sep; 130(9):4811-4830. PubMed ID: 32773408
[TBL] [Abstract][Full Text] [Related]
15. Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.
Kim Y; Hayashi M; Ono T; Yoda T; Takayanagi H; Nakashima T
Mod Rheumatol; 2020 Jan; 30(1):85-92. PubMed ID: 30486712
[No Abstract] [Full Text] [Related]
16. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.
Nakayachi M; Ito J; Hayashida C; Ohyama Y; Kakino A; Okayasu M; Sato T; Ogasawara T; Kaneda T; Suda N; Sawamura T; Hakeda Y
Bone; 2015 Jun; 75():170-82. PubMed ID: 25744064
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Osteoclasts Prime TNFα-Producing CD4
Ibáñez L; Abou-Ezzi G; Ciucci T; Amiot V; Belaïd N; Obino D; Mansour A; Rouleau M; Wakkach A; Blin-Wakkach C
J Bone Miner Res; 2016 Oct; 31(10):1899-1908. PubMed ID: 27161765
[TBL] [Abstract][Full Text] [Related]
18. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.
Darowish M; Rahman R; Li P; Bukata SV; Gelinas J; Huang W; Flick LM; Schwarz EM; O'Keefe RJ
Bone; 2009 Oct; 45(4):661-8. PubMed ID: 19524707
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
Tanaka K; Hashizume M; Mihara M; Yoshida H; Suzuki M; Matsumoto Y
Clin Exp Immunol; 2014 Feb; 175(2):172-80. PubMed ID: 24028747
[TBL] [Abstract][Full Text] [Related]
20. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.
Blüml S; Friedrich M; Lohmeyer T; Sahin E; Saferding V; Brunner J; Puchner A; Mandl P; Niederreiter B; Smolen JS; Schabbauer G; Redlich K
Ann Rheum Dis; 2015 Jan; 74(1):227-33. PubMed ID: 24078675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
